Home › NCT07087405
Striae Distensae Treatment Using Deep Skin Abrasion
Stretch Mark Treatment Using Subcutaneous Skin Abrasion
Who can join
Ages 18 to 70 · All sexes
Full eligibility criteria
Inclusion Criteria: * Striae distensae Exclusion Criteria: * Smoking * coagulation deficiency
About the study
The goal of this clinical trial is to learn if a device works to treat striae distensae. It will also learn about the safety of the device. The main questions it aims to answer are:
1. Does the device improve the appearance of striae distensae? 2. Does the device cause any problems when treating striae distensae? Researchers will compare the appearance of striae distensae before and after treatment with the device.
Participants will:
1. Undergo treatment with the device in the clinic 2. Visit the clinic 1 week, 3 months, and 1 year for checkups and tests
What is being tested
- Striae Distensae Treatment Device (device)
Sponsor: Boston Children's Hospital · Participants: 10 · Started: Oct 1, 2025
Contact the study team
- Arin Greene, MD · Phone: 16173552306
- Patrick Smits, PhD · Phone: 6173552306
Official record on ClinicalTrials.gov — NCT07087405
Locations in the U.S.
| Massachusetts | Boston Children's Hospital, Boston |
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.